Takeda Pharmaceutical (TAK) Change in Taxes (2018 - 2025)
Historic Change in Taxes for Takeda Pharmaceutical (TAK) over the last 6 years, with Q1 2025 value amounting to -$27.5 million.
- Takeda Pharmaceutical's Change in Taxes rose 9083.56% to -$27.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$612.1 million, marking a year-over-year decrease of 939.23%. This contributed to the annual value of $439.5 million for FY2025, which is 16933.47% up from last year.
- Takeda Pharmaceutical's Change in Taxes amounted to -$27.5 million in Q1 2025, which was up 9083.56% from $16.9 million recorded in Q4 2024.
- Takeda Pharmaceutical's Change in Taxes' 5-year high stood at $126.8 million during Q1 2023, with a 5-year trough of -$301.0 million in Q4 2023.
- Its 4-year average for Change in Taxes is -$95.0 million, with a median of -$56.2 million in 2022.
- Examining YoY changes over the last 5 years, Takeda Pharmaceutical's Change in Taxes showed a top increase of 10562.01% in 2024 and a maximum decrease of 33687.02% in 2024.
- Quarter analysis of 4 years shows Takeda Pharmaceutical's Change in Taxes stood at -$84.9 million in 2022, then tumbled by 254.52% to -$301.0 million in 2023, then skyrocketed by 105.62% to $16.9 million in 2024, then crashed by 262.76% to -$27.5 million in 2025.
- Its last three reported values are -$27.5 million in Q1 2025, $16.9 million for Q4 2024, and -$300.5 million during Q1 2024.